Search - tctmd.com

March 01, 2022

News Daily News

Financial Strain Ups Risk of Death After Acute MI in the Elderly

February 25, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

February 18, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

February 17, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

February 14, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

February 10, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

January 20, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

January 17, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Daily News

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

Caitlin E. Cox

January 07, 2022

News Daily News

Statins in Pregnancy Don’t Lead to Congenital Anomalies: Cohort Study

January 03, 2022

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Todd Neale

December 27, 2021

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

December 24, 2021

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

December 23, 2021

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

December 22, 2021

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

December 21, 2021

News Daily News

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

December 17, 2021

News Daily News

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

December 14, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

December 14, 2021

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF